68Ga-NODAGA-Exendin-4 PET/CT Findings in a Case of Metastatic Insulinoma With Refractory Hypoglycemia Controlled by 90Y Transarterial Radioembolization.
Clin Nucl Med · 2024
Last updated 2026-05-28A patient with metastatic insulinoma, which causes dangerously low blood sugar, saw improvement after two treatments of 90Y transarterial radioembolization. Imaging with 68Ga-NODAGA-exendin-4 PET/CT confirmed the presence of active cancer spread in the liver.
AI summary of the abstract below.
| Journal | Clin Nucl Med, 2024 |
|---|---|
| Citations | 1 |
| Relative citation ratio | 0.97 |
| NIH percentile | 49 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes |
Abstract
Metastatic insulinomas can cause recurrent hypoglycemia requiring continuous IV glucose infusion. Various medical and chemotherapeutic treatment options are used to reduce the patient's risk of death due to hypoglycemia. Treatment-resistant hepatic metastatic insulinomas may benefit clinically from 90Y transarterial radioembolization therapy. In this case, we present a case of liver metastatic insulinoma that achieved clinical improvement after 2 cycles of 90Y microspheres transarterial radioembolization, and the presence of active metastases was demonstrated with 68Ga-NODAGA-exendin-4 PET/CT imaging.
Verbatim abstract via PubMed 38967509 ↗